http://www.imdb.com/name/nm5037253/
In all of us there is this hunger to want to be better, to want to be stronger. Some achieve their goals, others give up. Every one of us has a choice, it's those who choose to never give up that are remembered.
What choice will you make?
http://www.weightdone.com Discover the best kept secrets to lose weight super fast. Losing weight has never been simpler. You will be surprised what happens next! It's not hard if you know the right tricks. Take action and your dream body is near.
SPANX®, the brand known for making women’s butts look better on red carpets and in offices around the world, leveled the playing field with the launch of SPANX for Men. The perfect gift for the dad who has everything - except maybe a flat stomach - the Cotton Compression Undershirt eliminates beer bellies and love handles while offering lumbar support. Due to the sellout success of the cotton shaping tees, Spanx launched Zoned Performance Undershirts that target the abs and torso with compression zones and Cotton Comfort Underwear featuring the perfect pouch with a horizontal fly for easy access and added support.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/spanx/49826/
http://www.bestworkoutdvdsx.com/info/hip-hop-abs-dvd/ Amazon Best Buy ( 4 out of 5 stars; 284 reviews) Best workout dvds - you learn tips and techniques from expert trainer Shaun T. Best workout dvds program helps to burn the fat from the stomach area and sculpt your abdominal muscles. Best workout dvds is very easy to follow and laid out effectively. Best workout dvds comes complete with a calendar, measurement card and also a tape measure, http://www.bestworkoutdvdsx.com/
Schockierende Ergebnisse beim aktuellen ADAC Werkstatt-Test: 78 Prozent der getesteten freien Werkstätten sind glatt durchgefallen - 28 von 36 untersuchten Betrieben haben die Bewertung „mangelhaft“ erhalten. Bei den Werkstatt-Ketten (A.T.U, Bosch, Meisterhaft und 1a Autoservice) sieht das Bild nur unwesentlich besser aus – hier fielen 17 von 36 Betrieben durch (47 Prozent). Des Weiteren zeigt der Test deutlich, dass die Freien bei der Inspektion nicht günstiger sind als die Ketten. Insgesamt enttäuschend bei dieser Stichprobe des ADAC: Von allen getesteten 72 Betrieben (Freie und Werkstatt-Ketten) erhielten gerade einmal sechs die Wertung „sehr gut“ (8 Prozent). Testgewinner bei den Ketten ist ein A.T.U-Betrieb in Hamburg (Heidhorst 3). Positiv: Keine einzige A.T.U-Werkstatt erhielt die Note mangelhaft. Den Testern des ADAC fiel bei A.T.U zudem auf, dass bei der Inspektionsannahme offen und realistisch über die voraussichtlichen Kosten gesprochen wird. Sechs der neun getesteten A.T.U-Service-Unternehmen fanden alle vom ADAC vorbereiteten Mängel. Bei den Bosch-Werkstätten fielen drei Betriebe durch, bei „1a“ sechs und bei Meisterhaft acht. Von allen freien Werkstätten hat Riegelhof Karosseriebau in Frankfurt/Main am besten abgeschnitten.Der Club hat die Werkstätten mit Fahrzeugen der Modelle Audi A3, Renault Megane und VW Golf 5 getestet. Vor der Prüfung wurden die Autos mit Mängeln präpariert: Ein verstelltes Scheinwerferlicht, eine defekte Kofferraumleuchte, ein ausgehängtes ABS-Kabel, ein zu niedriger Kühlmittelstand sowie ein Ersatzrad mit zu wenig Reifendruck, fehlendes oder abgelaufenes Pannenset. Die Arbeitsleistung wurde mit höchstens 60 Punkten, der Service mit maximal 40 Punkten bewertet. Punktabzug gab es, wenn wesentliche Serviceleistungen fehlten oder Zusatzarbeiten ohne vorherigen Auftrag ausgeführt wurden. Fazit des ADAC: Auch im Werkstatt-Test 2013 arbeiteten viele Betriebe die Inspektionsliste nicht sorgfältig ab, da nicht alle versteckten Fehler gefunden wurden. Nachholbedarf gibt es auch beim Kundenservice. Deshalb rät der Club den Verbrauchern, den Wagen zusammen mit dem Serviceberater anzuschauen und den Wartungsauftrag schriftlich zu erteilen. So werden Missverständnisse weitgehend ausgeschlossen.
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
